chrX-77508391-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 1P and 7B. PP2BP4_ModerateBP6BS2
The ENST00000373344.11(ATRX):c.7439G>A(p.Arg2480Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000281 in 1,209,533 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 7 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
ENST00000373344.11 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATRX | NM_000489.6 | c.7439G>A | p.Arg2480Lys | missense_variant | 35/35 | ENST00000373344.11 | NP_000480.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATRX | ENST00000373344.11 | c.7439G>A | p.Arg2480Lys | missense_variant | 35/35 | 1 | NM_000489.6 | ENSP00000362441 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0000358 AC: 4AN: 111586Hom.: 0 Cov.: 23 AF XY: 0.0000296 AC XY: 1AN XY: 33788
GnomAD3 exomes AF: 0.0000164 AC: 3AN: 183273Hom.: 0 AF XY: 0.0000148 AC XY: 1AN XY: 67759
GnomAD4 exome AF: 0.0000273 AC: 30AN: 1097947Hom.: 0 Cov.: 31 AF XY: 0.0000165 AC XY: 6AN XY: 363317
GnomAD4 genome AF: 0.0000358 AC: 4AN: 111586Hom.: 0 Cov.: 23 AF XY: 0.0000296 AC XY: 1AN XY: 33788
ClinVar
Submissions by phenotype
Alpha thalassemia-X-linked intellectual disability syndrome Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 02, 2023 | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 11, 2020 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Nov 13, 2019 | In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at